Healthcare provider profile · identity verified

Jeff Odiet, MD

Internal Medicine · PEABODY, MA · NPI 1093705832

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	566	162
Metoprolol Succinate	Metoprolol Succinate	445	123
Omeprazole	Omeprazole	423	122
Amlodipine Besylate	Amlodipine Besylate	416	112
Lisinopril	Lisinopril	398	107
Simvastatin	Simvastatin	292	81
Levothyroxine Sodium	Levothyroxine Sodium	272	72
Gabapentin	Gabapentin	251	60
Tamsulosin Hcl	Tamsulosin Hcl	192	55
Albuterol Sulfate Hfa	Albuterol Sulfate	182	57
Lorazepam	Lorazepam	163	49
Eliquis	Apixaban	156	32
Rosuvastatin Calcium	Rosuvastatin Calcium	148	41
Citalopram Hbr	Citalopram Hydrobromide	144	46
Hydrochlorothiazide	Hydrochlorothiazide	142	45
Sertraline Hcl	Sertraline Hcl	141	40
Metformin Hcl Er	Metformin Hcl	140	37
Trazodone Hcl	Trazodone Hcl	137	35
Oxycodone Hcl	Oxycodone Hcl	126	25
Furosemide	Furosemide	125	42
Alprazolam	Alprazolam	114	31
Losartan Potassium	Losartan Potassium	113	33
Fluticasone Propionate	Fluticasone Propionate	106	45
Pantoprazole Sodium	Pantoprazole Sodium	105	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	99	14
Glimepiride	Glimepiride	97	28
Allopurinol	Allopurinol	96	31
Clonazepam	Clonazepam	95	18
Tramadol Hcl	Tramadol Hcl	92	21
Metformin Hcl	Metformin Hcl	88	25
Clopidogrel	Clopidogrel Bisulfate	87	20
Atenolol	Atenolol	83	23
Famotidine	Famotidine	83	27
Zolpidem Tartrate	Zolpidem Tartrate	82	17
Celecoxib	Celecoxib	70	18
Trulicity	Dulaglutide	67	12
Ipratropium Bromide	Ipratropium Bromide	66	18
Doxycycline Monohydrate	Doxycycline Monohydrate	65	32
Baclofen	Baclofen	64	17
Potassium Chloride	Potassium Chloride	64	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	suppressed
Prednisone	Prednisone	62	35
Xarelto	Rivaroxaban	62	14
Mirtazapine	Mirtazapine	55	11
Finasteride	Finasteride	54	19
Ozempic	Semaglutide	54	11
Synthroid	Levothyroxine Sodium	53	15
Duloxetine Hcl	Duloxetine Hcl	52	12
Ezetimibe	Ezetimibe	52	16
Montelukast Sodium	Montelukast Sodium	52	16
Diazepam	Diazepam	50	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	50	11
Venlafaxine Hcl Er	Venlafaxine Hcl	49	12
Fluoxetine Hcl	Fluoxetine Hcl	48	15
Pravastatin Sodium	Pravastatin Sodium	48	13
Ventolin Hfa	Albuterol Sulfate	47	14
Warfarin Sodium	Warfarin Sodium	46	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	18
Diclofenac Sodium	Diclofenac Sodium	45	13
Incruse Ellipta	Umeclidinium Bromide	43	suppressed
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	suppressed
Testosterone Cypionate	Testosterone Cypionate	42	suppressed
Digoxin	Digoxin	39	suppressed
Torsemide	Torsemide	39	16
Pregabalin	Pregabalin	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Ondansetron Odt	Ondansetron	35	16
Alendronate Sodium	Alendronate Sodium	34	13
Jardiance	Empagliflozin	34	12
Ibuprofen	Ibuprofen	33	14
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	13
Fludrocortisone Acetate	Fludrocortisone Acetate	28	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	11
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Colchicine	Colchicine	27	11
Creon	Lipase/Protease/Amylase	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Carvedilol	Carvedilol	25	suppressed
Fluocinonide	Fluocinonide	25	15
Amoxicillin	Amoxicillin	24	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Morphine Sulfate	Morphine Sulfate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Azithromycin	Azithromycin	22	20
Chlorthalidone	Chlorthalidone	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Topiramate	Topiramate	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Cephalexin	Cephalexin	20	17
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Cefuroxime	Cefuroxime Axetil	19	15
Lovastatin	Lovastatin	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Linzess	Linaclotide	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Carisoprodol	Carisoprodol	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Testosterone	Testosterone	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Acamprosate Calcium	Acamprosate Calcium	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Nystatin	Nystatin	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error